Antibody suppression and antiallotype antibodies. II. Interference of circulating antiallotype antibodies with prophylactic treatment against Rh sensitization.
Sera from Rh-sensitized women representing presumable failure of the prophylactic treatment with IgG anti-D (Rh) have been examined for activity against allotype markers on IgG1. Antiallotype antibodies were found with increased frequency compared with a nonsensitized control. In general, however, interference of antiallotype antibodies is not considered to be a great risk of Rh prophylaxis at present. Some requirements which, in this context, may be of importance to the composition and dose of the IgG anti-D-containing preparations used are stressed.